NCT04931758

Brief Summary

In patients with chronic low back pain, the Fremantle Back Awareness Questionnaire (FreBAQ) measures the duration and intensity of pain and functional limitations. The FreBAQ is a simple tool created to assess disturbances in the body representation of the back, and the only one existing in chronic low back pain. It is a 9-item self-questionnaire in which each item is measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)". It assesses neglect, perceived body image of the back, accuracy in proprioceptive perception of back movements. The psychometric properties of the FreBAQ in English, Japanese, Dutch, Turkish and German are validated and acceptable; however, they have never been studied in French and no validated version of this questionnaire in French exists. The study investigators hypothesize that the French version of the FreBAQ has good psychometric qualities, allowing it to be used in the French chronic low back pain population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 18, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

May 23, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2023

Completed
Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

11 months

First QC Date

June 3, 2021

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pre-test of French version of FreBAQ on 20 representative patients

    9-item self-administered questionnaire newly translated into French using a standard translation-retro-translation system, each item measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)

    Baseline

Secondary Outcomes (16)

  • FreBAQ score

    Day 0

  • FreBAQ score in a subgroup of 50 subjects (35 patients and 15 controls)

    Day 7

  • Evaluation of the internal consistency of the French version of the FreBAQ

    Day 0

  • Evaluation of the unidimensionality of the French version of the FreBAQ

    Day 0

  • Assessment of the reliability (test-retest) of the questionnaire in French

    Day 7

  • +11 more secondary outcomes

Study Arms (2)

Patients with low back pain

Other: Pain Questionnaire

Controls

Other: Pain Questionnaire

Interventions

Subjects will take the FreBAQ questionnaire at Day 0 and a subgroup of 35 controls and 15 patients will take the same questionnaire at Day 7

ControlsPatients with low back pain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with chronic low back pain defined as pain localized between the edge of the last lower ribs and the intergluteal groove (17) for more than 3 months followed in the Physical Medicine and Rehabilitation Department of the CHU of Nîmes and persons recruited among the members of the service and their entourage, as well as all patients coming for consultation in the service with no history of chronic low back pain and lumbar VAS \< 2 for more than 3 months.

You may qualify if:

  • Subject with no history of chronic low back pain and with a lumbar VAS \<2 for more than 3 months.
  • Patient with chronic low back pain: pain localized between the edge of the last lower ribs and the intergluteal groove (17) for more than 3 months.
  • Patient with a lumbar VAS \> 2 for more than 3 months.
  • Patient whose low back pain is of common origin (no underlying organic etiology).
  • In case of lumbar-radicular pain, patient with a VAS (lumbar) \> VAS (leg)
  • Patient who speaks and understands French
  • Patient with no history of arthrodesis or lumbar disc prosthesis
  • Subject affiliated or beneficiary of a health insurance plan.
  • The patient must have given their free and informed consent and signed the consent form

You may not qualify if:

  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient pregnant, parturient or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nîmes

Nîmes, France

Location

Related Publications (1)

  • Homs AF, Ragon A, Mura T, Terribile G, Alonso S, Dupeyron AF. Validation of the French version of the Fremantle Back Awareness Questionnaire in patients with chronic low back pain. Eur J Phys Rehabil Med. 2025 Apr;61(2):295-304. doi: 10.23736/S1973-9087.24.08412-0. Epub 2025 Mar 10.

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alexis Homs

    CHU Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2021

First Posted

June 18, 2021

Study Start

May 23, 2022

Primary Completion

April 28, 2023

Study Completion

April 28, 2023

Last Updated

December 10, 2025

Record last verified: 2025-12

Locations